Combigan for Reduction of IOP for Glaucoma or Ocular Hypertension

The FDA has approved an ophthalmic solution that combines brimonidine and timolol or Combigan for reduction of intraocular pressure (IOP) in patients with glaucoma or ocular hypertension.

References and Resources
FDA

Sponsored by The Doctor’s Channel